Rin1, the prototype of a new family of multidomain Rab5 exchange factors, has been shown to play an important role in the endocytosis of the epidermal growth factor receptor (EGFR). Herein, we examined the role of Rin1 in the down-regulation of EGFR following EGF stimulation. We observed that overexpression of Rin1 accelerates EGFR degradation in EGF-stimulated cells. In concordance, depletion of endogenous Rin1 by RNA interference resulted in a substantial reduction of EGFR degradation. We showed that Rin1 interacts with signal-transducing adaptor molecule 2 (STAM2), a protein that associates with hepatocyte growth factor-regulated substrate and plays a key role in the endosomal sorting machinery. Green fluorescent protein (GFP)-Rin1 co-localizes with hemagglutinin (HA)-STAM2 and with endogenous hepatocyte growth factor-regulated substrate. Furthermore, wild type STAM2, but not a deletion mutant lacking the SH3 domain, co-immunoprecipitates with endogenous Rin1. This interaction is dependent on the proline-rich domain (PRD) of Rin1 as Rin1⌬PRD, a mutant lacking the PRD, does not interact with STAM2. Moreover, EGFR degradation was not accelerated by expression of the Rin1⌬PRD mutant. Together these results suggest that Rin1 regulates EGFR degradation in cooperation with STAM, defining a novel role for Rin1 in regulating endosomal trafficking.
The epidermal growth factor receptor (EGFR)2 plays a central role in cell proliferation, differentiation, survival, and migration (1, 2) and has served as a prototype in growth factor receptor trafficking. Following activation, EGFR with intrinsic tyrosine kinase activity is rapidly internalized by clathrincoated pits (3), sorted through early endosomes, and eventually transported to and degraded within multivesicular bodies (MVB) and lysosomes (4, 5). The process is generally known as receptor down-regulation and is considered to be an important cellular strategy for signal attenuation (6, 7). Alterations in receptor trafficking and signal attenuation have been associated with carcinogenesis (5, 8) and certain developmental processes, which has stimulated interest in the molecular mechanisms that regulate EGFR trafficking and degradation.EGFR targeted for lysosomal degradation is delivered to the MVB by a highly specialized process that begins with receptor ubiquitination and sequestration by elements of the ESCRT (endosomal sorting complex required for transport) complex on the surface of the early endosomes (9, 10). Invagination of the endosomal membrane and delivery of sequestered receptors into the lumen of the MVB is accompanied by receptor deubiquitination and disassembly of the ESCRT complex (11,12). The ESCRT machinery, first identified in yeast as class E Vps (vacuolar protein sorting) mutants (13) and highly conserved among eukaryotic cells (14), is important in targeting EGFR into the lumen of the MVB (15, 16). Substantial progress has been made in identifying the molecular mechanisms involved (12,17). Among the early acting factors are Hrs (hepatocyte growth fa...